Crown Bioscience Strategically Strengthens Leadership Team and Names New Chief Financial Officer

News provided by

Crown Bioscience Inc.

30 Aug, 2016, 08:00 ET

SANTA CLARA, Calif., Aug. 30, 2016 /PRNewswire/ -- Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, is pleased to announce that our President, Dr. Jean Pierre Wery, has now moved into the role of Chief Executive Officer.

In addition to Dr. Wery's recent nomination as CEO, Dr. Alex Wu, co-founder of CrownBio takes the role of President and Chief Strategy Officer, while Ms. Eva Ho has been appointed Chief Financial Officer.

"In 2016 CrownBio has experienced unprecedented growth with increasing demand for our Immuno-Oncology and Cardiovascular and Metabolic Disease services and models," says Wery. "As newly appointed CEO my objective is to foster the development of new products, cutting-edge technologies, and services for oncology and metabolic disease, while contemplating a possible expansion into new therapeutic areas."

To further demonstrate CrownBio's commitment to support its global growth, the Board of Directors has chosen Ms. Ho for the role of CFO. Ho brings years of experience in financial planning and analysis, having led the financial operations of well renowned global companies. Ho will take on Mr. Bing Zhu's previous role, who has now been appointed Chief Operating Officer.

"I am pleased Ms. Ho has joined CrownBio and I am looking forward to leading the next phase of the company's strategic initiatives," said Wu, CrownBio's co-founder and newly appointed President and CSO.

The consolidation of CrownBio's leadership team demonstrates the company's dedication to provide an experienced management team to drive forward the advancement of drug discovery worldwide.

For more information on CrownBio's commitment to furthering the field of oncology and metabolic disease drug discovery, visit www.crownbio.com.

About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, please visit www.crownbio.com.

Logo - http://photos.prnewswire.com/prnh/20160405/351602LOGO

SOURCE Crown Bioscience Inc.

Related Links

http://www.crownbio.com

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.